| Literature DB >> 36246962 |
Osama M Alshehri1, Saleh Alshamrani1, Mater H Mahnashi2, Mohammed Merae Alshahrani3, Jalwa Ali Khan4, Muhammad Shah5, Mohammed Ali Alshehri6, Rehman Zafar7, Muhammad Zahoor8, Muhammad Saeed Jan4, Syed Shams Ul Hassan9,10, Abdul Sadiq11.
Abstract
Cancer is one of the most challenging diseases in the modern era for the researchers and investigators. Extensive research worldwide is underway to find novel therapeutics for prevention and treatment of diseases. The extracted natural sources have shown to be one of the best and effective treatments for cell proliferation and angiogenesis. Different approaches including disc potato model, brine shrimp, and chorioallantoic membrane (CAM) assay were adopted to analyze the anticancer effects. Habenaria digitata was also evaluated for MTT activity against NIH/3T3 cell line. The dexamethasone, etoposide, and vincristine sulfate were used as a positive control in these assays. All of the extracts including crude extracts (Hd.Cr), saponin (Hd.Sp), n-hexane (Hd.Hx), chloroform (Hd.Chf), ethyl acetate (Hd.EA), and aqueous fraction (Hd.Aq) were shown excellent results by using various assays. For example, saponin and chloroform have displayed decent antitumor and angiogenic activity by using potato tumor assay. The saponin fraction and chloroform were shown to be the most efficient in potato tumor experiment, demonstrating 87.5 and 93.7% tumor suppression at concentration of 1000 μg/ml, respectively, with IC50 values of 25.5 and 18.3 μg/ml. Additionally, the two samples, chloroform and saponins, outperformed the rest of the test samples in terms of antiangiogenic activity, with IC50 28.63 μg/ml and 16.20 μg/ml, respectively. In characterizing all solvent fractions, the chloroform (Hd.Chf) and saponin (Hd.Sp) appeared to display good effectiveness against tumor and angiogenesis but very minimal activity against A. tumefaciens. The Hd.Chf and Hd.Sp have been prospective candidates in the isolation of natural products with antineoplastic properties.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36246962 PMCID: PMC9553491 DOI: 10.1155/2022/9051678
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Total flavonoids and phenolic contents of H. digitata crude methanolic extract and their subsequent fractions.
| Sample content | Sample total phenolic (mg GAE/g) | Sample total flavonoid (mg RTE/g) |
|---|---|---|
| Hd.Cf | 178.61 ± 0.66 | 132.43 ± 1.10 |
| Hd.EA | 220.44 ± 0.82 | 98.44 ± 1.88 |
| Hd.Cr | 98.52 ± 1.50 | 72.75 ± 0.67 |
| Hd.Hx | 30.32 ± 1.70 | 14.32 ± 0.52 |
| Hd.Aq | 41.43 ± 0.73 | 21.50 ± 0.54 |
Phytochemical ingredients in crude fraction of H. digitata.
| S. no | Phytochemicals | Observations | Results |
|---|---|---|---|
| 1. | Alkaloids | Turbidity | + |
| 2. | Glycosides | Red color precipitate formation | + |
| 3. | Tannins | Bluish black color formation | + |
| 4. | Terpenoids | Reddish brown color appearance | + |
| 5. | Anthraquinones | Reddish violet color | + |
| 6. | Flavonoids | Yellow color formation and changed colorless when acid is added | + |
| 7. | Saponins | Frothing bubble formation | + |
| 8. | Oils | Greasy spot formation | + |
| 9. | Sterols | Green to pink color was absent | − |
Phytochemicals present = positive sign; phytochemicals absent = negative sign.
Various samples of antiangiogenic activity of H. digitata.
| Sample | Percentage angiogenic activity mean ± SEM ( | IC50 | |||||
|---|---|---|---|---|---|---|---|
| 31.25 | 62.5 | 125 | 250 | 500 | 1000 | ||
| Hd.Cr | 29.24 ± 0.22∗∗∗ | 36.30 ± 1.50∗∗∗ | 40.52 ± 0.60∗∗∗ | 45.98 ± 1.03∗∗∗ | 52.37 ± 0.35∗∗∗ | 65.35 ± 0.86∗∗∗ | 460.51 |
| Hd.Hx | 21.92 ± 0.51∗∗∗ | 25.34 ± 1.32∗∗∗ | 26.68 ± 0.91∗∗∗ | 32.52 ± 0.88∗∗∗ | 39.85 ± 1.38∗∗∗ | 43.55 ± 0.44∗∗∗ | 1530.44 |
| Hd.Cf | 51.01 ± 1.52∗∗∗ | 55.10 ± 1.80∗∗∗ | 61.35 ± 0.66∗∗∗ | 60.95 ± 1.23∗∗∗ | 69.98 ± 1.66∗∗∗ | 78.65 ± 1.66∗∗∗ | 28.63 |
| Hd.EA | 44.50 ± 0.56∗∗∗ | 48.52 ± .0.88∗∗∗ | 52.68 ± 1.62∗∗∗ | 56.05 ± 0.84∗∗∗ | 61.02 ± 1.13∗∗∗ | 69.41 ± 1.13∗∗∗ | 86.73 |
| Hd.Aq | 24.02 ± 0.25∗∗∗ | 27.10 ± 1.17∗∗∗ | 28.35 ± 0.33∗∗∗ | 39.35 ± 0.90∗∗∗ | 52.68 ± 1.47∗∗∗ | 61.44 ± 1.43∗∗∗ | 430.80 |
| Hd.Sp | 54.64 ± 0.70∗∗∗ | 58.22 ± 0.72∗∗∗ | 59.89 ± 0.28∗∗∗ | 64.20 ± 1.17∗∗ | 68.45 ± 0.99∗ | 76.98 ± 1.03ns | 16.20 |
Positive control was taken as dexamethasone, with IC50 data of 11.66 μg/ml. Values significantly vary as compared to the standard drug with probability ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 at 90% confidence interval. ns: values not significantly different in contrast to standard drug.
Figure 1Antiangiogenic activity of various extract of the H. digitata.
Figure 2Anticancer compounds reported from H. digitata.
Various samples of antitumor activity of H. digitata.
| Sample content | Concentration ( | Inhibition in average (mean ± SEM) | Inhibition percentage (mean ± SEM) | IC50 ( |
|---|---|---|---|---|
| Hd.Cr | 1000 | 24.7 ± 0.3 | 86.4 ± 1.1∗∗∗ | 195.7 |
| 500 | 18.0 ± 0.6 | 64.3 ± 1.9∗∗∗ | ||
| 250 | 15.0 ± 1.2 | 54.4 ± 2.8∗∗∗ | ||
| 125 | 13.3 ± 0.0 | 44.6 ± 1.1∗∗∗ | ||
| 62.5 | 11.0 ± 0.3 | 39.0 ± 0.0∗∗∗ | ||
| 31.25 | 10.0 ± 0.6 | 33.5 ± 1.9∗∗∗ | ||
|
| ||||
| Hd.Hex | 1000 | 20.0 ± 0.4 | 62.3 ± 1.7∗∗∗ | 390.2 |
| 500 | 17.3 ± 0.5 | 53.4 ± 1.9∗∗∗ | ||
| 250 | 13.7 ± 1.2 | 41.2 ± 1.1∗∗∗ | ||
| 125 | 12.0 ± 0.3 | 35.7 ± 2.8∗∗∗ | ||
| 62.5 | 11.5 ± 0.9 | 33.5 ± 1.1∗∗∗ | ||
| 31.25 | 09.0 ± 0.6 | 25.7 ± 0.0∗∗∗ | ||
|
| ||||
| Hd.Chf | 1000 | 25.0 ± 1.2 | 87.5 ± 2.8∗ | 25.5 |
| 500 | 22.5 ± 0.5 | 78.8 ± 1.1∗∗ | ||
| 250 | 20.0 ± 0.0 | 71.7 ± 0.0∗∗∗ | ||
| 125 | 18.7 ± 0.3 | 66.5 ± 2.2∗∗ | ||
| 62.5 | 16.2 ± 0.6 | 59.0 ± 1.7∗∗∗ | ||
| 31.25 | 14.7 ± 0.6 | 51.0 ± 1.9∗∗∗ | ||
|
| ||||
| Hd.EA | 1000 | 25.0 ± 0.6 | 81.1 ± 1.7∗∗ | 60.3 |
| 500 | 20.5 ± 0.7 | 66.4 ± 0.2∗∗∗ | ||
| 250 | 19.0 ± 0.6 | 61.7 ± 1.9∗∗∗ | ||
| 125 | 17.6 ± 1.2 | 54.0 ± 0.2∗∗∗ | ||
| 62.5 | 16.2 ± 0.0 | 50.2 ± 2.8∗∗∗ | ||
| 32.25 | 14.4 ± 0.2 | 44.4 ± 1.8∗∗∗ | ||
|
| ||||
| Hd.Aq | 1000 | 14.0 ± 0.2 | 46.2 ± 0.4∗∗∗ | 1110.7 |
| 500 | 12.2 ± 0.4 | 42.0 ± 1.1∗∗∗ | ||
| 250 | 11.3 ± 0.7 | 38.8 ± 1.8∗∗∗ | ||
| 125 | 9.7 ± 0.9 | 30.0 ± 0.4∗∗∗ | ||
| 62.5 | 8.2 ± 0.0 | 28.2 ± 0.8∗∗∗ | ||
| 31.25 | 5.3 ± 0.5 | 17.9 ± 0.1∗∗∗ | ||
|
| ||||
| Hd.Sp | 1000 | 28.2 ± 0.8 | 92.7 ± 0.0ns | 18.3 |
| 500 | 25.7 ± 0.1 | 82.3 ± 1.9∗ | ||
| 250 | 23.0 ± 0.0 | 77.6 ± 1.2∗ | ||
| 125 | 19.5 ± 0.3 | 62.9 ± 1.9∗∗ | ||
| 62.5 | 17.1 ± 0.9 | 55.2 ± 0.0∗∗∗ | ||
| 31.25 | 16.8 ± 0.4 | 53.3 ± 0.5∗∗ | ||
Positive control was taken as vincristine sulfate having IC50value < 0.1 μg/ml; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 Hd.Cr crude methanol extract, Hd.Hex fraction of n-hexane, Hd.Chf fraction of chloroform, Hd.EA fraction of ethyl acetate, Hd.Aq fraction of aqueous layer, Hd.Sp fractions of saponins. ns: nonsignificant.
Concentration-dependent cytotoxicity of H. digitata crude extract and resultant fraction values against Artemia salina (brine shrimps) and their LC50 values.
| Samples | Total treated | Concentration dose (mg/ml) | Killed nauplii ( | Killed mean | Percent cytotoxicity | LC50 (mg/ml) | ||
|---|---|---|---|---|---|---|---|---|
| I | II | III | ||||||
| Hd.Cr | 30 | 1000 | 18 | 22 | 17 | 19.00 ± 0.58 | 64.1 ± 1.5 | 262 |
| 100 | 14 | 15 | 14 | 14.33 ± 0.56 | 47.6 ± 1.9 | |||
| 10 | 10 | 12 | 14 | 11.33 ± 0.52 | 37.4 ± 1.3 | |||
|
| ||||||||
| Hd.Hx | 30 | 1000 | 17 | 18 | 19 | 18.00 ± 0.04 | 60.2 ± 0.4 | 630 |
| 100 | 11 | 12 | 10 | 11.00 ± 0.06 | 36.7 ± 0.8 | |||
| 10 | 07 | 08 | 07 | 07.33 ± 0.58 | 24.4 ± 1.9 | |||
|
| ||||||||
| Hd.Chf | 30 | 1000 | 22 | 24 | 24 | 23.31 ± 0.56 | 77.4 ± 1.7 | 51 |
| 100 | 17 | 19 | 17 | 17.66 ± 0.57 | 58.7 ± 2.2 | |||
| 10 | 12 | 13 | 14 | 13.00 ± 0.20 | 43.5 ± 0.7 | |||
|
| ||||||||
| Hd.EA | 30 | 1000 | 21 | 21 | 19 | 20.33 ± 0.56 | 67.6 ± 1.7 | 481 |
| 100 | 11 | 13 | 11 | 11.67 ± 0.54 | 38.7 ± 1.5 | |||
| 10 | 08 | 09 | 10 | 09.01 ± 0.02 | 30.0 ± 0.4 | |||
|
| ||||||||
| Hd.Aq | 30 | 1000 | 18 | 19 | 20 | 19.00 ± 0.20 | 63.5 ± 0.2 | 420 |
| 100 | 12 | 13 | 14 | 13.00 ± 0.04 | 43.1 ± 0.4 | |||
| 10 | 08 | 10 | 10 | 09.33 ± 0.56 | 31.3 ± 1.7 | |||
|
| ||||||||
| Hd.Sp | 30 | 1000 | 29 | 29 | 29 | 29.00 ± 0.20 | 96.5 ± 0.2 | <0.01 |
| 100 | 22 | 22 | 20 | 21.33 ± 0.56 | 71.3 ± 1.7 | |||
| 10 | 17 | 17 | 18 | 17.67 ± 0.54 | 58.7 ± 1.5 | |||
Positive control (etoposide LD50 9.8). PPM = part per million; SD = standard deviation; Unbiased = s=
Cytotoxicity study results utilizing mouse embryonic fibroblast (NIH/3T3 cell line).
| Sample content | Concentration ( | Cell viability percentage | Cytotoxicity percentage | LC50 ( |
|---|---|---|---|---|
| Hd.Cr | 1000 | 30.77 ± 0.52 | 66.30∗∗∗ | 282 |
| 500 | 41.43 ± 0.64 | 58.57∗∗∗ | ||
| 250 | 53.00 ± 1.10 | 47.00∗∗∗ | ||
| 125 | 61.00 ± 0.10 | 39.00∗∗∗ | ||
| 62.5 | 66.00 ± 0.00 | 34.00∗∗∗ | ||
| 31.25 | 68.10 ± 0.80 | 31.90∗∗∗ | ||
|
| ||||
| Hd.Hex | 1000 | 21.20 ± 0.59 | 78.80∗∗∗ | 561 |
| 500 | 26.00 ± 1.17 | 74.00∗∗∗ | ||
| 250 | 43.50 ± 0.22 | 57.00∗∗∗ | ||
| 125 | 48.00 ± 0.00 | 52.00∗∗∗ | ||
| 62.5 | 56.20 ± 0.52 | 43.80∗∗∗ | ||
| 31.25 | 61.00 ± 0.50 | 39.00∗∗∗ | ||
|
| ||||
| Hd.Chf | 1000 | 22.00 ± 0.18 | 78.00∗∗∗ | 142 |
| 500 | 27.00 ± 1.17 | 73.00∗∗∗ | ||
| 250 | 44.00 ± 0.46 | 56.00∗∗∗ | ||
| 125 | 49.00 ± 0.00 | 51.00∗∗∗ | ||
| 62.5 | 56.00 ± 0.22 | 44.00∗∗∗ | ||
| 31.25 | 60.00 ± 0.00 | 40.00∗∗∗ | ||
|
| ||||
| Hd.EA | 1000 | 28.16 ± 1.04 | 71.84∗∗∗ | 158 |
| 500 | 38.00 ± 1.17 | 62.00∗∗∗ | ||
| 250 | 46.18 ± 0.18 | 53.82∗∗∗ | ||
| 125 | 59.00 ± 0.00 | 41.00∗∗∗ | ||
| 62.5 | 67.44 ± 0.22 | 32.56∗∗∗ | ||
| 32.25 | 73.50 ± 0.00 | 26.50∗∗∗ | ||
|
| ||||
| Hd.Aq | 1000 | 47.66 ± 1.22 | 52.34∗∗∗ | 785 |
| 500 | 51.66 ± 0.44 | 48.34∗∗∗ | ||
| 250 | 59.00 ± 1.19 | 41.00∗∗∗ | ||
| 125 | 70.33 ± 0.55 | 29.67∗∗∗ | ||
| 62.5 | 82.00 ± 0.00 | 18.00∗∗∗ | ||
| 31.25 | 87.00 ± 0.88 | 13.00∗∗∗ | ||
|
| ||||
| Hd.Sp | 1000 | 28.50 ± 1.20 | 71.50∗∗∗ | 172 |
| 500 | 34.66 ± 1.33 | 65.34∗∗∗ | ||
| 250 | 46.00 ± 0.00 | 54.00∗∗∗ | ||
| 125 | 55.22 ± 1.17 | 44.78∗∗∗ | ||
| 62.5 | 67.00 ± 0.00 | 33.00∗∗∗ | ||
| 31.25 | 72.33 ± 0.44 | 27.67∗∗∗ | ||
|
| ||||
| Negative control | — | 100 | 0 | — |
Standard drug etoposide as positive control; LD50 was 5.46 μg/ml. Values were identified as significantly different in comparison to the standard drug; ∗∗∗p < 0.001.